Previous 10 | Next 10 |
home / stock / rhhbf / rhhbf news
2023-08-03 08:52:55 ET More on Aravive Aravive: Very Small Company With Late Stage Trial In Ovarian Cancer Aravive stock pops on FDA orphan drug status for batiraxcept to treat pancreatic cancer Aravive gains on FDA Fast Track status for lead program Aravive ...
2023-08-02 08:56:23 ET More on TG Therapeutics TG Therapeutics: The Hype Is Gone TG Therapeutics: Fairly Valued After Earnings Miss, EU Deal (Rating Upgrade) TG Therapeutics: Addressing The SC Ocrevus Concern TG Therapeutics falls as Roche succeeds in Phase 3...
2023-08-01 12:57:01 ET Summary Roche reports Q2 financial results in line with expectations and confirms 2023 guidance. Diagnostic turnover declines due to lower COVID-19 sales. Excluding that, Pharma and Diagnostics grew by 7% and 8% in Q2, showing a solid recovery. Guidance ...
2023-07-30 09:05:25 ET Summary Alnylam partnered Roche to develop and commercialize zilebesiran for the treatment of hypertension. Alnylam's share price has not benefited as the announcement was followed by the company revealing a very long development timeline for the candidate. ...
2023-07-29 21:50:55 ET Summary The launch of Briumvi is off to a solid start, but the stock pulled back recently and fell more after Roche reported positive phase 3 results of subcutaneously administered Ocrevus. The improved convenience of SC Ocrevus is an overblown risk factor, ...
2023-07-27 09:40:36 ET Summary The news on Starpharma share price is challenging as a significant shareholder exits. The news of commercially interesting developments continues to broaden, meaning that substantial share price upside seems likely. Starpharma has a strong board ...
2023-07-26 15:04:29 ET The World Health Organization updated its Essential Medicines List on Wednesday without adding a class of weight loss medications called glucagon-like peptide-1 (GLP-1) receptor agonists as a treatment for obesity. The list designed to guide state procurement deci...
2023-07-21 14:53:45 ET PTC Therapeutics ( NASDAQ: PTCT ) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency, recommended extending the marketing authorization for its Roche ( OTCQX:RHHBY )-partnered treatment Evrysdi to include infants ...
2023-07-17 10:51:59 ET Summary Johnson & Johnson will release its second quarter earnings report on July 20 before the market opens. I share my thoughts on the upcoming earnings release, focusing on the ongoing talc litigation and the anticipated spinoff/split-off of the remai...
2023-07-16 20:14:12 ET UK-based HSBC initiated coverage of 19 major biopharma stocks this past week, labeling Roche ( OTCQX:RHHBY ) ( OTCQX:RHHBF ), Merck KGaA ( OTCPK:MKGAF ) ( OTCPK:MKKGY ) and Lonza ( OTCPK:LZAGY ) ( OTCPK:LZAGF ) as potential comeback stories, wh...
News, Short Squeeze, Breakout and More Instantly...
Economist Impact report, Advancing the frontier of health and technology integration: The 2023 Digital Health Barometer highlights opportunities in digitalisation of healthcare Canada NewsWire The report shows digital health technologies demonstrate value, yet integrating th...
Development in Alzheimer's disease diagnosis in Canada: New tests help patients and caregivers make timely decisions Canada NewsWire Roche's Cerebrospinal Fluid (CSF) assays address unmet needs in the detection of amyloid pathology by offering greater accessibility and support...